ARTA
VYNT

A.R.T. Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

A.R.T. Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-155
Closed -$24K – 1767
2018
Q3 		$24K Buy
+155
New +$22.9K ﹤0.01% 1342
2016
Q1 		– Sell
-219
Closed -$108K – 1729
2015
Q4 		$108K Buy
219
+125
+133% +$90.3K 0.01% 1318
2015
Q3 		$109K Buy
+94
New +$144K ﹤0.01% 1241

Other funds holding VYNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

A.R.T. Advisors's VYNT Position: Q4 2018 in Review

A.R.T. Advisors sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2018, closing a stake of 155 shares — an estimated $24K sold.

A.R.T. Advisors first reported a position in VYNT in Q3 2015 and held it in 3 quarters. The position peaked at $109K in Q3 2015. 27 funds tracked by Wall St. Rank hold VYNT as of Q4 2018.

  • A.R.T. Advisors reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 155 Vyant Bio, Inc. Common Stock shares in Q4 2018, an estimated $24K.
  • A.R.T. Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • A.R.T. Advisors's Vyant Bio, Inc. Common Stock position peaked at $109K in Q3 2015.
  • 27 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.